Pasithea Therapeutics Corp.
KTTA
$0.956
$0.095411.09%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.18M | -3.00M | -3.87M | -3.86M | -5.05M |
| Total Depreciation and Amortization | 162.30K | 162.30K | 162.30K | 162.30K | 162.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 117.00K | 218.20K | 196.60K | 319.80K | -472.00K |
| Change in Net Operating Assets | 455.40K | -501.10K | -531.40K | -942.30K | 1.45M |
| Cash from Operations | -2.44M | -3.12M | -4.04M | -4.32M | -3.91M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 54.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 594.40K |
| Cash from Investing | -- | -- | -- | -- | 648.90K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 300.00 | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -23.90K | 4.54M | -- | -- | -- |
| Cash from Financing | -23.60K | 4.54M | -- | -- | 0.00 |
| Foreign Exchange rate Adjustments | 28.10K | -27.10K | -2.90K | -600.00 | 3.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.44M | 1.39M | -4.04M | -4.32M | -3.25M |